Status:
ACTIVE_NOT_RECRUITING
A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Smoking
Eligibility:
FEMALE
50-80 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to develop a digital strategy to increase awareness about lung cancer screening among women who are eligible to receive it. The digital strategy involves email communicati...
Eligibility Criteria
Inclusion
- LDCT screening-eligible women who received a BiRADS 1 (negative) or 2 (benign/non-cancerous finding) result from a screening mammogram in the last 7 days
- Age 50-80 years
- ≥ 20-pack-year smoking history of combustible cigarettes as per self report
- Women who currently smoke or quit within past 15 years as per self report
- Lung screening naïve as per self-report
Exclusion
- Lung cancer diagnosis
- Chest CT within the last 12 months
Key Trial Info
Start Date :
April 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 9 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04848961
Start Date
April 9 2021
End Date
April 9 2026
Last Update
August 14 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, United States, 07920
2
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, New Jersey, United States, 07748
3
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, United States, 07645
4
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)
Commack, New York, United States, 11725